SIRT1-mediated deacetylation of TRIM21 promotes IRF5 degradation and restrains type I interferon signatures in Sjögren's disease.
INTRODUCTION Persistently activated type I interferon (IFN) signaling is a key factor in glandular dysfunction of Sjögren's disease(SjD), with elevated "type I interferon signatures" observed in both peripheral blood and salivary gland tissues of affected patients. However, the intrinsic mechanisms suppressing this res...